Dr. Thomas-Duythuc Ngoc To, MD

Dr. To practices at Renown Regional Medical Center in Reno, Nevada, part of Renown Health.

Dr. To's NPI, 1215129044, was assigned on August 15, 2007. Dr. To graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2007. Dr. To holds Nevada license 15275.

Dr. To's primary practice is Renown Regional Medical Center, at 1155 Mill Street, Reno, NV 89502 in Washoe County. The practice phone is (775) 982-4100.

Dr. To's primary practice is Renown Regional Medical Center in Reno, Nevada, part of Renown Health. Dr. To is also affiliated with Renown South Meadows Medical Center. The medical group on file is Renown Health. Dmand AI also links Dr. To to 3 more hospitals, 5 group practices and clinics and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. To practices, 10 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. To's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. To is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. To's licenses on file in 2 states: Nevada and California.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, chronic embolism thrombosis, chronic hypertension, coronary artery disease, heart blockage and heart failure among the conditions Dr. To treats.

CMS data shows 5,224 Medicare services from Dr. To across 34 procedure codes in 2024, for 2,352 Medicare patients. Medicare paid $181,831 for them.

CMS counts 2,352 Medicare patients who saw Dr. To in 2024. The largest group is 65 to 74, with 970 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. To's median patient age at 73, with 46% women.

In 2024, Dr. To wrote 9,682 Medicare Part D claims for 1,117 patients. 72% of them were for generic drugs. CMS names the drug for 9,399 of them, across 56 drugs with 11 or more claims each, at $3,440,578 in total drug cost. In 2023, CMS named 8,522 claims across 62 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. To for performance year 2024, reported as part of a group. Dr. To accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. To as offering telehealth. CMS counts 63 procedures of varicose vein removal by Dr. To, more than 77% of the clinicians it reports for that procedure.

CMS Open Payments shows 889 general payments to Dr. To from 36 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $220,688.

Dr. To graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2007. Dr. To is a member of ACC.

Dr. To is in network with 10 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. HMO plans come from the most carriers, 5. Check the plan with the practice before a visit.